Hepatitis B Virus (HBV) Load Response to 2 Antiviral Regimens, Tenofovir/Lamivudine and Lamivudine, in HIV/ HBV-Coinfected Pregnant Women in Guangxi, China: The Tenofovir in Pregnancy (TiP) Study
Conclusions. Initiation of either regimen led to achievement of HBV DNA levels below the threshold associated with perinatal HBV transmission.
Clinical Trials Registration. NCT01125696.
Source: The Journal of Infectious Diseases - Category: Infectious Diseases Authors: Wang, L., Wiener, J., Bulterys, M., Wei, X., Chen, L., Liu, W., Liang, S., Shepard, C., Wang, L., Wang, A., Zhang, F., Kourtis, A. P. Tags: HIV/AIDS Source Type: research
More News: Antiviral Therapy | Clinical Trials | Hepatitis | Hepatitis B | HIV AIDS | Infectious Diseases | Perinatology & Neonatology | Pregnancy | Study | Viread | Virology | Women